Literature DB >> 10569926

Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria.

Y Wang1, M E Henz, N L Gallagher, S Chai, A C Gibbs, L Z Yan, M E Stiles, D S Wishart, J C Vederas.   

Abstract

Carnobacteriocin B2 (CbnB2), a type IIa bacteriocin, is a 48 residue antimicrobial peptide from the lactic acid bacterium Carnobacterium pisicola LV17B. Type IIa bacteriocins have a conserved YGNGVXC sequence near the N-terminus and usually contain a disulfide bridge. CbnB2 seemed to be unique in that its two cysteines (Cys9 and Cys14) could be isolated as free thiols [Quadri et al. (1994) J. Biol. Chem. 26, 12204-12211]. To establish the structural consequences of the presence or absence of a disulfide bridge and to investigate if the YGNGVXC sequence is a receptor-binding motif [Fleury et al. (1996) J. Biol. Chem. 271, 14421-14429], the three-dimensional solution structure of CbnB2 was determined by two-dimensional (1)H nuclear magnetic resonance (NMR) techniques. Mass spectroscopic and thiol modification experiments on CbnB2 and on model peptides, in conjunction with activity measurements, were used to verify the redox status of CbnB2. The results show that CbnB2 readily forms a disulfide bond and that this peptide has full antimicrobial activity. NMR results indicate that CbnB2 in trifluoroethanol (TFE) has a well-defined central helical structure (residues 18-39) but a disordered N terminus. Comparison of the CbnB2 structure with the refined solution structure of leucocin A (LeuA), another type IIa bacteriocin, indicates that the central helical structure is conserved between the two peptides despite differences in sequence but that the N-terminal structure (a proposed receptor binding site) is not. This is unexpected because LeuA and CbnB2 exhibit >66% sequence identity in the first 24 residues. This suggests that the N-terminus, which had been proposed [Fleury et al. (1996) J. Biol. Chem. 271, 14421-14429] to be a receptor binding site of type IIa bacteriocins, may not be directly involved and that recognition of the amphiphilic helical portion is the critical feature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569926     DOI: 10.1021/bi991351x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.

Authors:  G Fimland; L Johnsen; L Axelsson; M B Brurberg; I F Nes; V G Eijsink; J Nissen-Meyer
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Engineering increased stability in the antimicrobial peptide pediocin PA-1.

Authors:  L Johnsen; G Fimland; V Eijsink; J Nissen-Meyer
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

3.  Rapid two-step procedure for large-scale purification of pediocin-like bacteriocins and other cationic antimicrobial peptides from complex culture medium.

Authors:  Marianne Uteng; Håvard Hildeng Hauge; Ilia Brondz; Jon Nissen-Meyer; Gunnar Fimland
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

Review 4.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

5.  Determination of essential and variable residues in pediocin PA-1 by NNK scanning.

Authors:  Tatsuya Tominaga; Yoshinori Hatakeyama
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

6.  Insights into structure-activity relationships in the C-terminal region of divercin V41, a class IIa bacteriocin with high-level antilisterial activity.

Authors:  Jitka Rihakova; Vanessa W Petit; Katerina Demnerova; Hervé Prévost; Sylvie Rebuffat; Djamel Drider
Journal:  Appl Environ Microbiol       Date:  2009-01-30       Impact factor: 4.792

Review 7.  An expanding universe of small proteins.

Authors:  Errett C Hobbs; Fanette Fontaine; Xuefeng Yin; Gisela Storz
Journal:  Curr Opin Microbiol       Date:  2011-02-20       Impact factor: 7.934

8.  Mutational analysis of mesentericin y105, an anti-Listeria bacteriocin, for determination of impact on bactericidal activity, in vitro secondary structure, and membrane interaction.

Authors:  Dany Morisset; Jean-Marc Berjeaud; Didier Marion; Christian Lacombe; Jacques Frère
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

9.  Structure and Mode-of-Action of the Two-Peptide (Class-IIb) Bacteriocins.

Authors:  Jon Nissen-Meyer; Camilla Oppegård; Per Rogne; Helen Sophie Haugen; Per Eugen Kristiansen
Journal:  Probiotics Antimicrob Proteins       Date:  2009-11-03       Impact factor: 4.609

10.  Defining the structure and receptor binding domain of the leaderless bacteriocin LsbB.

Authors:  Kirill V Ovchinnikov; Per E Kristiansen; Gordana Uzelac; Ljubisa Topisirovic; Milan Kojic; Jon Nissen-Meyer; Ingolf F Nes; Dzung B Diep
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.